SEP15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.324200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.136600E-01
Normal-vs-Stage2
9.089000E-01
Normal-vs-Stage3
8.171400E-01
Normal-vs-Stage4
3.761600E-01
Stage1-vs-Stage2
6.230200E-01
Stage1-vs-Stage3
9.539200E-01
Stage1-vs-Stage4
2.859000E-01
Stage2-vs-Stage3
6.346800E-01
Stage2-vs-Stage4
4.530800E-01
Stage3-vs-Stage4
3.731400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.430000E-01
Normal-vs-AfricanAmerican
5.812200E-01
Normal-vs-Asian
7.041400E-01
Caucasian-vs-AfricanAmerican
3.269000E-01
Caucasian-vs-Asian
3.368000E-01
AfricanAmerican-vs-Asian
2.414600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.020200E-01
Normal-vs-Female
7.377800E-01
Male-vs-Female
7.296000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.748400E-01
Normal-vs-Age(41-60Yrs)
5.030000E-01
Normal-vs-Age(61-80Yrs)
9.106400E-01
Normal-vs-Age(81-100Yrs)
7.652000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.264220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.295600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.280600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.270030E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.600400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.127800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.989600E-01
Normal-vs-Daily Drinker
9.242400E-01
Normal-vs-Weekly Drinker
4.951000E-01
Normal-vs-Occasional Drinker
2.835600E-01
Normal-vs-Social Drinker
8.688000E-01
Non Drinker-vs-Daily Drinker
4.478200E-01
Non Drinker-vs-Weekly Drinker
6.094200E-01
Non Drinker-vs-Occasional Drinker
1.757990E-03
Non Drinker-vs-Social Drinker
5.559400E-01
Daily Drinker-vs-Weekly Drinker
3.255800E-01
Daily Drinker-vs-Occasional Drinker
4.559600E-02
Daily Drinker-vs-Social Drinker
9.144400E-01
Weekly Drinker-vs-Occasional Drinker
4.800700E-03
Weekly Drinker-vs-Social Drinker
3.903400E-01
Occasional Drinker-vs-Social Drinker
4.113600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.063600E-01
Normal-vs-Grade 2
7.618000E-01
Normal-vs-Grade 3
8.264200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.316340E-02
Grade 1-vs-Grade 3
2.405600E-01
Grade 1-vs-Grade 4
9.063600E-01
Grade 2-vs-Grade 3
1.542630E-01
Grade 2-vs-Grade 4
7.618000E-01
Grade 3-vs-Grade 4
8.264200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.611800E-01
Normal-vs-NonDiabetic
9.814400E-01
Diabetic-vs-NonDiabetic
3.132600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.079000E-01
Normal-vs-NoPancreatitis
9.767800E-01
Pancreatitis-vs-NoPancreatitis
7.734600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.343600E-01
Normal-vs-N1
8.910000E-01
N0-vs-N1
8.592800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.394600E-01
Normal-vs-TP53-NonMutant
8.561000E-01
TP53-Mutant-vs-TP53-NonMutant
7.497800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
